Pharmacy benefit cost increased 7.7% this year, after rising 8.4% in 2023, propelled by greater use of GLP-1 drugs for diabetes and weight loss, the survey of 2,194 employers found
Why Combine Cagrilintide with Retatrutide
Lab Results vs
revenue in Q4 2024, a sharp rise from USD 175.8 million in Q4 2023
The more lean mass you keep, the higher your resting metabolism, the better your blood sugar control, and the easier it is to maintain your results long-term
GLP-1 weight loss medications have become a cornerstone of medically supervised weight loss , helping patients reduce appetite, improve portion control, and support sustainable fat loss